论文部分内容阅读
为探讨罗红霉素治疗解脲支原体 (UU)感染性宫颈炎的临床效果 ,将 86例UU感染性宫颈炎患者随机分为 2组 ,A组 (4 3例 )给予口服罗红霉素胶囊 ;B组 (4 3例 )给予口服强力霉素片 ,观察其疗效及副作用 .结果表明 :罗红霉素治疗UU感染性宫颈炎的痊愈率为 95% ,明显高于强力霉素 6 7% (P <0 .0 1) ,而且罗红霉素的副作用发生率仅为 2 .33% ,明显低于强力霉素18.6 % (P <0 .0 5) .因此提议将罗红霉素作为目前治疗UU感染的首选药物之一 .
To investigate the clinical effect of roxithromycin in the treatment of UU-infected cervicitis, 86 cases of UU-infected cervicitis were randomly divided into two groups. Group A (43 cases) received oral roxithromycin capsules (43 cases) were given oral doxycycline tablets to observe the curative effect and side effects.The results showed that the cure rate of roxithromycin in treating UU cervicitis was 95%, which was obviously higher than that of doxycycline 67% (P <0.01), and the incidence of side effects of roxithromycin was only 2.33%, which was significantly lower than that of doxycycline (18.6%, P <0.05), so roxithromycin was proposed as One of the drug of choice for the current treatment of UU infection.